Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I8BO
|
|||
| Former ID |
DNC013997
|
|||
| Drug Name |
1-(5-(furan-2-yl)oxazol-2-yl)octadec-9-en-1-one
|
|||
| Synonyms |
CHEMBL174048; 1-(5-(furan-2-yl)oxazol-2-yl)octadec-9-en-1-one; SCHEMBL3196395; BDBM50157127; (Z)-1-(5-Furan-2-yl-oxazol-2-yl)-octadec-9-en-1-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H37NO3
|
|||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CO2
|
|||
| InChI |
1S/C25H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-22(27)25-26-21-24(29-25)23-19-17-20-28-23/h9-10,17,19-21H,2-8,11-16,18H2,1H3/b10-9-
|
|||
| InChIKey |
RZGSPAWMLKONHZ-KTKRTIGZSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Aug 14;51(15):4392-403. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.